The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis
Open accessAbstract
Background Treatment with the combination of aspirin and a P2Y12 inhibitor is commonly employed in a number of cardiovascular conditions. The overall impact of such treatment on all-cause mortality is unknown. In the Dual Antiplatelet Therapy (DAPT) Study, an international multicenter randomized placebo-controlled trial comparing 30 versus 12 months of dual antiplatelet therapy after coronary stenting, continuation of DAPT beyond 12 months was associated with an increase in mortality at trial completion, largely attributable to an increase in non-cardiovascular death. Given the potential public health importance of this, we performed a meta-analysis of all randomized, controlled trials of DAPT duration across a wide array of cardiovascular conditions to evaluate the impact of extended duration DAPT on mortality. Methods A systematic literature search of MEDLINE, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) database was performed to identify randomized controlled trials evaluating the impact of extended duration versus no or short-duration DAPT. Study results were pooled using a hierarchical Bayesian random-effects model. The primary outcomes examined were hazard ratios comparing rates of all-cause, cardiovascular, and non-cardiovascular death. Findings Including the DAPT Study, we identified 14 eligible trials that randomized 69,644 subjects to different durations of DAPT. Compared with aspirin alone or short-duration DAPT (≤ 6 months), continued DAPT was not associated with a difference in all-cause mortality (hazard ratio [HR] 1·05; 95% credible interval [CrI], 0·96–1·19). Similarly, cardiovascular (HR 1·01; 95% CrI, 0·93–1·12) and non-cardiovascular mortality (HR 1·04; 95% CrI, 0·90–1·26) were no different with extended duration vs. short duration DAPT or aspirin alone. Interpretation In a meta-analysis of 14 trials, extended duration DAPT was not associated with a difference in the risk of all-cause, cardiovascular, or non-cardiovascular death compared with aspirin alone or short duration DAPT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Mauri, L., Kereiakes, D. J., Yeh, R. W., Driscoll-Shempp, P., Cutlip, D. E., Steg, P. G., Normand, S.-L. T., Braunwald, E., Wiviott, S. D., Cohen, D. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409312 · Cited by 1,928
Self-citationThe BUGS project: evolution, critique and future directions
Lunn, D., Spiegelhalter, D., Thomas, A., & Best, N. (2009) · Statistics in Medicine · doi:10.1002/sim.3680 · Cited by 1,876
Effects of clopidogrel added to aspirin in patients with recent lacunar stroke
The SPS3 Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204133 · Cited by 679
Cited by
Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.513 · Cited by 1,641
Self-citationLevine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000404 · Cited by 1,355
Self-citationPalmerini, T., Benedetto, U., Bacchi-Reggiani, L., Riva, D. D., Biondi-Zoccai, G., Feres, F., Abizaid, A., Hong, M.-K., Kim, B.-K., Jang, Y., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60263-x · Cited by 396
Udell, J. A., Bonaca, M. P., Collet, J.-P., Lincoff, A. M., Kereiakes, D. J., Costa, F., Lee, C. W., Mauri, L., Valgimigli, M., Park, S.-J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv443 · Cited by 370
Self-citationDuration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
Giustino, G., Baber, U., Sartori, S., Mehran, R., Mastoris, I., Kini, A. S., Sharma, S. K., Pocock, S. J., & Dangas, G. D. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.039 · Cited by 344
Metadata
- Authors
- Elmariah, S., Mauri, L., Doros, G., Galper, B. Z., O'Neill, K. E., Steg, P. G., Kereiakes, D. J., & Yeh, R. W.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 385
- Issue
- 9970
- Pages
- 792-798
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2136520492
- Cited by
- 168
- References
- 6
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1016/s0140-6736(14)62052-3
- The paper
- Elmariah, S., Mauri, L., Doros, G., Galper, B. Z., O'Neill, K. E., Steg, P. G., Kereiakes, D. J., & Yeh, R. W. (2015). Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis. The Lancet. https://doi.org/10.1016/s0140-6736(14)62052-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.